Terms: = Brain cancer AND CANT1, ENSG00000171302, 124583, Q8WVQ1, SHAPY, SCAN-1 AND Treatment
4 results:
1. Pan-cancer analysis predicts cant1 as a potential prognostic, immunologic biomarker.
Yang W; Liu Z; Liu T
Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
[TBL] [Abstract] [Full Text] [Related]
2. Time-delayed contrast-enhanced MRI improves detection of brain metastases and apparent treatment volumes.
Kushnirsky M; Nguyen V; Katz JS; Steinklein J; Rosen L; Warshall C; Schulder M; Knisely JP
J Neurosurg; 2016 Feb; 124(2):489-95. PubMed ID: 26361281
[TBL] [Abstract] [Full Text] [Related]
3. Delayed contrast extravasation MRI: a new paradigm in neuro-oncology.
Zach L; Guez D; Last D; Daniels D; Grober Y; Nissim O; Hoffmann C; Nass D; Talianski A; Spiegelmann R; Tsarfaty G; Salomon S; Hadani M; Kanner A; Blumenthal DT; Bukstein F; Yalon M; Zauberman J; Roth J; Shoshan Y; Fridman E; Wygoda M; Limon D; Tzuk T; Cohen ZR; Mardor Y
Neuro Oncol; 2015 Mar; 17(3):457-65. PubMed ID: 25452395
[TBL] [Abstract] [Full Text] [Related]
4. Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel.
Matsuoka M; Boku N; Yoshino T; Hironaka S; Onozawa Y; Fukutomi A; Zenda S; Yamazaki K; Yasui H; Hasuike N; Inui T; Yamaguchi Y; Ono H; Kamata M
Int J Clin Oncol; 2005 Dec; 10(6):429-32. PubMed ID: 16369748
[TBL] [Abstract] [Full Text] [Related]
